Status:
RECRUITING
Characteristics and Results of Patients Treated by Therapeutic Intensification
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Malignant Hemopathy
Eligibility:
All Genders
18+ years
Brief Summary
Many studies have focused on patients treated with allogeneic peripheral stem cell transplantation; few studies have until now been carried out to describe the characteristics and results of autograft...
Eligibility Criteria
Inclusion
- Adult patient (≥18 years old)
- Gender indifferent
- Admitted to the Intensive Care Unit within thirty days following therapeutic intensification and autograft of peripheral stem cells for the treatment of a hematologic malignancy between 01/01/2013 and 12/31/2022
Exclusion
- \- Subject having expressed his opposition to the reuse of his data for scientific research purposes
Key Trial Info
Start Date :
January 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 20 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06894381
Start Date
January 20 2024
End Date
December 20 2025
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Médecine Intensive - Réanimation - CHU de Strasbourg - France
Strasbourg, France, 67091